Human leukocyte antigens as genetic markers in colorectal carcinoma

Diseases of the Colon and Rectum

Volumn 42, Issue 1, 1999, Pages 66-70

  Chatzipetrou, M A ^a   Tarassi, K E ^b   Konstadoulakis, M M ^a   Pappas, H E ^b   Zafirellis, K D ^a   Athanassiades, T E ^b   Papadopoulos, S A ^a   Panousopoulos, D G ^a   Golematis, B C ^a   Papasteriades, C A ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Colorectal carcinoma; Genetic markers; Human leukocyte antigens

Indexed keywords

HLA A1 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DQ ANTIGEN;

ADULT; AGED; COLORECTAL CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; SEROLOGY;

EID: 0032947496     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02235184     Document Type: Conference Paper

References (26)

1. Juhasz F, Boros P, Szegedi G, et al. Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer 1989;63:1318-26.
2. Rigopoulou D, Martinez-Laso J, Martinez-Tello F, et al. Both class I and class II HLA antigens are thyroid cancer susceptibility factors. Tissue Antigens 1994;43:281-5.
3. Wank R, Thomsen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQW3. Nature 1991;352:723-5.
4. Barger BO, Acton RT, Soong SJ, Roseman J, Balch C. Increase of HLA-DR4 in melanoma patients from Alabama. Cancer Res 1982;42:4276-9.
5. Lee JE, Reveille JD, Ross MI, Platsoucas CD. HLA-DQ 1*0301 association with increased cutaneous melanoma risk. Int J Cancer 1994;59:510-3.
6. Kratzik C, Aiginger P, Kuber W, et al. Risk factors for bilateral testicular germ cell tumors. Cancer 1991;68: 916-21.
7. Sory A, Gorski A, Misiuna P, Wallner G, Polkowski W. Is gastric cancer heterogeneity the clue to HLA-DR associated susceptibility? Acta Oncol 1994;33:976-7.
8. Hilton DA, West KP. An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma. Cancer 1990;66:1154-7.
9. Levin VI, Muravskaia GV, Buglova EE, et al. The distribution of HLA-system antigens in lung cancer patients. Vopr Onkol 1991;37:280-3.
10. Toumbis M, Zervas J, Anagnostopoulou O, et al. HLA antigens and bronchogenic carcinoma in the Greek population. Acta Oncol 1991;30:575-8.
11. Dawkins RL, Christiansen FT, Kay PH, et al. Disease associations with complotypes, supratypes, and haplotypes. Immunol Rev 1983;70:5-22.
12. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA;1995;45:8-30.
13. Lynch HT, Watson P, Smyrk TC, et al. Colon cancer genetics. Cancer Suppl 1992;70:1300-12.
14. Winawer SJ, Enker WE, Levin B. Colorectal cancer. In: Winawer SJ (ed) Management of gastrointestinal diseases. New York: Gower Medical Publishing, 1992;27: 1-40.
15. Rozen P, Lynch HT, Figer A, et al. Familial colon cancer in the Tel-Aviv area and the influence of ethnic origin. Cancer 1987;60:2355-9.
16. Burt RW, Bishop DT, Cannon LA, Dowdle MA, Lee RG, Skolnick MH. Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 1985;312:1540-4.
17. Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 1988;319:533-7.
18. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;204:998-1000.
19. Vartdal F, Gaudernack G, Funderud S, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation - a fast and reliable technique. Tissue Antigens 1986;28:301-12.
20. Yagita A, Abe O, Sekiguchi S. HLA type in patients with colon and rectum cancer and ulcerative colitis with special reference to cancer susceptibility [in Japanese], Cancer Chemother 1977;4:939-45.
21. Sakellariou B, Mavroyannis C, Kapellou P, et al. HLA-A,B antigens and colorectal neoplasms [in Greek]. Arch Greek Med 1985;2:138-40.
22. Alcalay M, Bontoux D, Maire PH, Matuchanscky CL, Alcalay D, Tanzen J. HLA-B27 and colorectal cancer. N Engl J Med 1982;307:443-4.
23. Lio D, Caccamo N, D'Anna C, et al. Viral antibody titers are influenced by HLA-DR2 phenotype. Exp Clin Immunogenet 1994;11:182-6.
24. Kaloterakis A, Papasteriades C, Filliotou A, Economidou J, Hadjiyannis S, Stratigos J. HLA in familial and nonfamilial Mediterranean Kaposi's sarcoma in Greece. Tissue Antigens 1995;45:117-9.
25. Papasteriades C, Arseniou P, Bicas N, Ioannides G, Thalassinos N. HLA antigens in Greek type I diabetics, 11th International Histocompatibility Workshop and Conference. Yokohama, Book of Abstracts, Nishimura H, Sasazuki T (eds), Kyushu University, Fukuoka, Japan 1991;167.
26. Salgame P, Convit J, Bloom BR. Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. Proc Natl Acad Sci USA 1991; 88:2598-602.